Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

Severe COVID-19 often leads to hair loss in India.

Vaccination helps reduce long COVID symptoms in women with PCOS.

COVID-19 can cause different skin issues, including rashes and hair loss.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

COVID-19 survivors may face long-term health issues affecting both mind and body.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Women are more likely to have long-term post-COVID symptoms than men.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 reinfection may trigger alopecia areata.